POCT Equipments: Building the Future of Patient-Centric Diagnostics

Dr Smeet Shah, Executive Director, Sameer Shah, Managing Director

Dr Smeet Shah, Executive Director

Sameer Shah, Managing Director

The in-vitro diagnostics (IVD) industry is undergoing a fundamental transformation as healthcare systems worldwide move towards faster, more accessible, and decentralized testing. From hospitals and diagnostic lab­oratories to emergency care units and community health­care settings, the demand for rapid and reliable diagnos­tic solutions has never been greater.

Point-of-Care Testing (POCT), automation, and integrated diagnostic platforms are redefining how healthcare providers diagnose and treat patients, reducing turnaround times and enabling quicker clinical decisions.

As this evolution reshapes the diagnostics landscape, POCT Equipments has emerged as a trusted partner within the IVD ecosystem. The company serves hospitals, laborato­ries, healthcare institutions, government organizations, and global partners through a comprehensive portfolio of diag­nostic products and solutions.

However, POCT Equipments is more than a supplier of diagnostic equipment. Its foun­dation is built upon a clear vision: bringing quality diagnos­tics closer to patients and enabling healthcare professionals to make faster, more informed decisions. This philosophy, shaped by the industry experience of Managing Director Sameer Shah and strengthened by the strategic leadership of Executive Director Dr Smeet Shah, continues to guide the company's growth and future ambitions.

Why POCT Equipments Was Born

The story of POCT Equipments begins with the professional journey of Sameer Shah, a diagnostics industry veteran with more than three decades of experience in healthcare. Before establishing the company in 2019, Sameer Shah spent nearly twenty years with Abbott Point of Care, where he worked extensively with corporate hospitals, private healthcare institutions, laboratories, and critical care environments across India.

During this period, he witnessed the growing global adoption of Point-of-Care Testing and its ability to transform patient care. Unlike conventional diagnostic workflows that require samples to be sent to centralized laboratories, POCT enables testing to be performed at or near the patient's bed­side, allowing clinicians to receive results within minutes and initiate treatment without delay.

For Sameer Shah, this was not simply a technological advancement; it represented a fundamental shift in healthcare delivery. He recognized that India's healthcare ecosystem would increasingly require decentralized diagnostic solutions capable of delivering faster results, improved efficiency, and better patient outcomes. This conviction became the driving force behind the creation of POCT Equipments.

“The company's name itself reflects this vision. POCT Equipments was deliberately named after Point-of-Care Testing because the concept lies at the heart of its mission. The organization was founded on the belief that diagnostics should move closer to the patient, reducing therapeutic turnaround times and enabling healthcare professionals to make timely clinical decisions when every minute matters”, speaks Sameer Shah, Managing Director.

POCT Equipments has developed a business model centered on these principles by working exclusively with authorized manufacturers and certified partners that adhere to internationally recognized quality standards

Dr Smeet Shah, Executive Director, Sameer Shah, Managing Director

From Diagnostics Supplier to Integrated Healthcare Solutions Partner

Since its inception, POCT Equipments has steadily expanded its role within the diagnostics ecosystem. The company functions as an integrated solutions provider, offering rapid diagnostic kits, point-of-care testing systems, pathology analyzers, laboratory consumables, reagents, and related healthcare solutions through a structured and quality-focused supply framework.

A significant chapter in the company's growth began in 2021 when Executive Director Dr Smeet Shah joined the organization. A qualified Bachelor of Dental Surgery (BDS), Dr Smeet Shah initially pursued clinical practice before choosing to transition into the healthcare and diagnostics business, driven by a broader interest in advancing healthcare delivery and innovation.

Under his leadership, POCT Equipments entered a new phase of expansion. While the company initially focused primarily on pathology laboratory solutions, Dr Smeet Shah played a key role in broadening its business footprint by establishing dedicated hospital, veterinary, government, and export divisions. His efforts have helped diversify the company's operations while strengthening its presence across multiple healthcare segments.

Dr Smeet Shah's approach combines operational discipline with a forward-looking vision. By focusing on strategic partnerships, quality-certified sourcing, and market-driven ex pansion, he has helped position POCT Equipments as a comprehensive diagnostic solutions provider capable of serving diverse customer needs across domestic and international markets.

Advancing Diagnostics through Quality, Innovation, and Trust

In a sector where diagnostic accuracy directly influences patient outcomes, trust is built through consistency, quality, and regulatory compliance. POCT Equipments has developed a business model centered on these principles by working exclusively with authorized manufacturers and certified partners that adhere to internationally recognized quality standards.

“The company's commitment extends beyond product distribution. Its operational framework emphasizes disciplined sourcing, quality validation, documentation, compliance management, and continuous performance monitoring. This structured approach enables healthcare providers to access reliable diagnostic solutions while minimizing supply chain uncertainties”, shares Dr Smeet Shah, Executive Director.

At the same time, POCT Equipments remains focused on the future of diagnostics. The company closely follows developments in automation, digital diagnostics, laboratory connectivity, and AI-enabled healthcare technologies.

Both Sameer Shah and Dr Smeet Shah believe that innovation must deliver practical clinical value rather than simply introduce complexity. As a result, the organization continues to evaluate technologies that enhance efficiency, improve diagnostic accuracy, and strengthen healthcare accessibility.

A Vision Aligned with India's Diagnostics Future

Looking ahead, POCT Equipments aims to establish itself as a comprehensive diagnostic solutions platform serving the entire diagnostics value chain. The company's long-term strategy includes expanding its product portfolio, strengthening OEM and private-label initiatives, enhancing its presence across healthcare segments, and supporting the growing adoption of point-of-care testing and decentralized diagnostics.

For Sameer Shah, the future lies in making high-quality diagnostics more accessible to healthcare providers and patients alike. For Dr Smeet Shah, it is about building a future-ready organization that combines innovation, quality, and global competitiveness.

Together, their vision extends beyond business growth. It encompasses strengthening healthcare infrastructure, supporting domestic manufacturing, creating employment opportunities, and contributing to a more efficient and patient-focused healthcare ecosystem.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.